MedPath

Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder System

Not Applicable
Conditions
Radiographic Contrast Agent Nephropathy
Registration Number
NCT01778140
Lead Sponsor
Taipei Medical University
Brief Summary

The investigators hypothesize that a Clinical Decision Support System (CDSS) designed with "Patient-Specific" reminders yields superior performance than that with "Non-patient-specific" reminders in preventing contrast-induced nephropathy.

Detailed Description

We hypothesize that a clinical decision support system (CDSS) designed with "Patient-specific" reminders yields superior performance than that with "Non-patient-specific" reminders in preventing contrast-induced nephropathy.

A 3-arm randomized controlled trial (RCT) will be performed by cluster randomization using physicians as the unit of allocation. Physicians in 3 university medical centers will be randomly assigned into 1) patient-specific arm with Anti Contrast-Induced-Nephropathy(Anti-CIN) reminder, 2) non-patient-specific reminder arm, and 3) the control arm without any reminders, respectively.

The patient-specific alert, Anti-CIN system, is designed as a real-time CDSS implementation on CPOE for monitoring physician's contrast-enhanced CT and IVP orders. Computerized pop-up reminders provide the patient-specific encounters with optimal decision options when patients are at a high CIN risk or patients with unknown risk factors are encountered. Non-patient-specific reminders always pop up no matter whether the patient is at a high risk or not.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Our intervention targets are physicians but not patients. All physicians working in the hospital may join this trial.
Exclusion Criteria
  • The physician who never orders a CT scan or IVU study will be excluded
  • The physician who never operates the CPOE by himself or herself will be excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The percentage of contrast-enhanced imaging(CEI) orders with high CIN riskPhysicains who participated in this trial will be followed for an expected average of 12 months

The number of CEI ordered for patients at high CIN risk, divided by the total number of CEI orders. \[CEI\]: contrast-enhanced image studies,such as CT or IVU. \[CIN\]: contrast-induced nephropathy

Secondary Outcome Measures
NameTimeMethod
The order elimination rate of high CIN risk orders attributed to the computerized reminderPhysicains who participated in this trial will be followed for an expected average of 12 months

The number of CEI orders with high CIN risk cancelled by the physician attributed to our computerized reminder, divided by the total number of CEI orders with high CIN risk.

Trial Locations

Locations (1)

Taipei medical university hospital

🇨🇳

Taipei, Taiwan

Taipei medical university hospital
🇨🇳Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath